Pantoprazol Sun (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazol Sun, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related gastrointestinal conditions in adults.

GNH USA supplies Pantoprazol Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Sun belongs to the proton pump inhibitor class and is indicated for conditions involving excess stomach acid. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates mucosal healing and reduces further erosion. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Pantoprazol Sun may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools that resolve after continued therapy. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea with abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat, or seizures. - Bone fractures: increased risk with long‑term use, especially in older adults.

When prescribing Pantoprazol Sun, consider patient‑specific factors and monitor for potential complications. - Assess renal function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Evaluate need for long‑term therapy: limit duration when possible to reduce fracture risk. - Monitor electrolytes: especially magnesium during prolonged treatment. - Counsel patients on symptom monitoring: report persistent diarrhea or signs of infection. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Sun can affect the absorption or metabolism of several co‑administered drugs.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect, increasing cardiovascular risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR; monitor coagulation parameters. - Methotrexate: increased serum levels, especially at high doses. - Digoxin: modest increase in serum concentration; observe for toxicity signs.